A 2026 cross-sectional study of 80 pregnant women found that those delivering babies early had significantly higher vitamin D levels than those delivering at full term (27.49 versus 23.34 ng/mL), though both groups remained below normal ranges. According to Gram Research analysis, this unexpected finding suggests vitamin D status may be connected to early preterm birth risk, but the study was too small to prove cause and effect, and larger research is needed before changing clinical practice.
Researchers compared vitamin D levels and a genetic marker called microRNA-1323 in 80 pregnant women to understand what might cause early preterm birth. They found that women who delivered early had higher vitamin D levels than those who delivered at full term, though both groups had lower-than-normal vitamin D. The genetic marker showed a similar pattern but wasn’t statistically significant. According to Gram Research analysis, these findings suggest vitamin D status may play a role in early preterm delivery, though more research is needed to understand exactly how.
Key Statistics
A 2026 cross-sectional study of 80 pregnant women found that maternal vitamin D levels were significantly higher in women with early preterm births (27.49 ng/mL) compared to full-term births (23.34 ng/mL), a difference of 4.15 ng/mL.
In a 2026 study of 80 pregnant women, both the early preterm group and term group had vitamin D levels below the normal range recommended during pregnancy, despite the early preterm group having statistically significantly higher levels.
A 2026 analysis of 80 pregnant women found no significant correlation between maternal vitamin D levels and microRNA-1323 expression in either the early preterm or term delivery groups, suggesting these biomarkers operate independently.
The Quick Take
- What they studied: Whether vitamin D levels and a genetic marker in maternal blood differ between women who deliver babies early (before 34 weeks) versus at full term (37-42 weeks)
- Who participated: 80 pregnant women total: 40 who delivered babies early (between 28-34 weeks of pregnancy) and 40 who delivered at full term. All were measured at the time of delivery.
- Key finding: Women with early preterm births had vitamin D levels that were 4.15 ng/mL higher on average than women with full-term births (27.49 versus 23.34 ng/mL). This difference was statistically significant, meaning it wasn’t due to chance. However, both groups had vitamin D levels below what doctors consider normal.
- What it means for you: This research suggests vitamin D status may be connected to early preterm birth risk, but it’s too early to change your vitamin D habits based on this study alone. Talk to your doctor about appropriate vitamin D levels during pregnancy. This is one small study that needs to be confirmed by larger research before making clinical recommendations.
The Research Details
This was a cross-sectional study, which means researchers took a snapshot in time by measuring vitamin D and a genetic marker in blood samples from 80 pregnant women at delivery. They compared two groups: 40 women who delivered babies early (between 28-34 weeks) and 40 who delivered at full term (37-42 weeks). The researchers measured vitamin D using a standard lab test called ELISA, which detects the specific form of vitamin D in blood called calcidiol. They also measured microRNA-1323 expression using a molecular technique that counts how much of this genetic marker was present in each blood sample. All measurements were taken at the time of delivery, and researchers then compared the results between the two groups using statistical tests.
This research approach is important because it allows researchers to identify potential biological differences between women who deliver early versus at full term. By measuring these markers at delivery, researchers can see if they’re associated with preterm birth. However, because this is a cross-sectional study, it only shows association, not cause and effect. The study helps identify which biomarkers might be worth investigating further in larger, more detailed studies.
This study has moderate reliability. Strengths include using standardized laboratory methods to measure vitamin D and genetic markers, and having equal-sized groups for comparison. Limitations include the small sample size of only 80 women, which limits how much we can generalize the findings. The study is observational rather than experimental, so it cannot prove that vitamin D causes preterm birth. Additionally, the study didn’t measure other important factors that might affect preterm birth risk, such as maternal age, nutrition, stress, or infections. The lack of correlation between the two biomarkers suggests they may work independently, which wasn’t fully explored.
What the Results Show
The main finding was that maternal vitamin D levels (measured as calcidiol) were significantly higher in women who had early preterm births compared to women with full-term births. Specifically, the early preterm group averaged 27.49 ng/mL while the term group averaged 23.34 ng/mL, a difference of about 4.15 ng/mL. This difference was statistically significant, meaning researchers are confident it wasn’t due to random chance. However, it’s important to note that both groups had vitamin D levels below the normal range that doctors typically recommend during pregnancy. The second biomarker studied, microRNA-1323, also showed higher expression in the early preterm group, but this difference was not statistically significant. This means the difference could have been due to chance. Interestingly, when researchers looked for a connection between vitamin D levels and microRNA-1323 expression, they found no significant correlation in either group. This suggests these two biomarkers may operate independently and don’t directly influence each other.
The study found that both biomarkers showed trends toward higher levels in the early preterm group, even though only vitamin D reached statistical significance. This pattern suggests that biological changes associated with early preterm birth might involve multiple systems in the body. The fact that vitamin D levels were below normal in both groups raises questions about whether vitamin D deficiency itself might be a risk factor for preterm birth, regardless of delivery timing. The lack of correlation between the two biomarkers indicates they likely reflect different biological processes and may need to be studied separately to understand their individual roles in preterm birth.
Previous research has suggested that vitamin D plays a role in pregnancy outcomes, with some studies linking low vitamin D to increased preterm birth risk. This study’s finding of higher vitamin D in the preterm group is somewhat unexpected and differs from some prior research. However, the finding that both groups had below-normal vitamin D levels aligns with other studies showing vitamin D deficiency is common in pregnant populations. The microRNA-1323 finding is novel, as this specific genetic marker hasn’t been extensively studied in relation to preterm birth. The lack of correlation between vitamin D and microRNA-1323 suggests these may be independent risk factors, which differs from some theories that linked vitamin D to epigenetic regulation.
This study has several important limitations. First, the sample size of 80 women is relatively small, which limits how much the findings can be applied to larger populations. Second, the study is observational and cross-sectional, meaning it only shows associations at one point in time and cannot prove that vitamin D causes preterm birth. Third, the study didn’t measure many other factors that influence preterm birth, such as maternal age, body weight, smoking status, infections, stress levels, or nutrition. Fourth, blood samples were taken only at delivery, so researchers don’t know if vitamin D levels changed during pregnancy or what levels were earlier in pregnancy. Fifth, the study didn’t include information about vitamin D supplementation during pregnancy, which could affect results. Finally, the lack of statistical significance for microRNA-1323 means this finding is less reliable and needs confirmation in larger studies.
The Bottom Line
Based on this single study, there are no new clinical recommendations for vitamin D supplementation in pregnancy. Current medical guidelines already recommend that pregnant women maintain adequate vitamin D levels, typically 30 ng/mL or higher. This study suggests vitamin D status may be connected to preterm birth risk, but more research is needed before changing clinical practice. Pregnant women should follow their doctor’s recommendations for vitamin D screening and supplementation based on their individual risk factors and local guidelines. Confidence level: Low to Moderate, as this is a small, observational study that needs confirmation.
This research is most relevant to pregnant women, especially those at risk for early preterm birth, and their healthcare providers. Women with a history of preterm birth, multiple pregnancies, or other risk factors should discuss vitamin D status with their doctors. Healthcare providers caring for pregnant patients should be aware of this potential association but should not change clinical practice based on this single study. Researchers studying preterm birth causes should consider this finding when designing future studies. Women who are not pregnant do not need to change their vitamin D habits based on this research.
If vitamin D status does influence preterm birth risk, the effect would occur during pregnancy, with the most critical period likely being the second and third trimesters. However, this study doesn’t tell us when vitamin D levels matter most or how quickly changes in vitamin D status might affect risk. Any clinical changes based on vitamin D supplementation would need to be implemented early in pregnancy to potentially have an effect. Realistic expectations: This is early-stage research, and it may take several years of additional studies before clear clinical recommendations emerge.
Frequently Asked Questions
Does low vitamin D cause early preterm birth?
This study found higher vitamin D in early preterm births, which is unexpected. Both groups had below-normal vitamin D levels. The research cannot prove vitamin D causes preterm birth because it’s observational. More research is needed to understand the relationship.
Should pregnant women take vitamin D supplements to prevent preterm birth?
Current medical guidelines already recommend adequate vitamin D during pregnancy. This single study doesn’t change those recommendations. Talk to your doctor about appropriate vitamin D supplementation based on your individual risk factors and local guidelines.
What is microRNA-1323 and why does it matter for preterm birth?
MicroRNA-1323 is a genetic marker in blood that may reflect biological changes in the body. This study found it was slightly higher in early preterm births but not significantly. Its role in preterm birth is not yet understood and needs further investigation.
How reliable is this study for making decisions about my pregnancy?
This is early-stage research with a small sample size of 80 women. It shows an interesting association but cannot prove cause and effect. Discuss these findings with your healthcare provider rather than making changes based on this study alone.
What should I do if I’m pregnant and worried about preterm birth?
Follow your doctor’s prenatal care recommendations, including vitamin D screening if recommended. Report any warning signs like vaginal bleeding, fluid leakage, or contractions immediately. Maintain regular prenatal visits and discuss your individual risk factors with your healthcare provider.
Want to Apply This Research?
- Pregnant users should track their vitamin D supplementation dose and timing, along with their delivery outcome and gestational age at delivery. Record weekly vitamin D intake in international units (IU) or micrograms, and note any lab results showing vitamin D levels. This data can help users and their healthcare providers identify patterns and ensure adequate vitamin D status throughout pregnancy.
- Users can set a daily reminder to take their prenatal vitamin with vitamin D, or to take a separate vitamin D supplement as recommended by their doctor. The app could provide education about vitamin D-rich foods and sun exposure recommendations during pregnancy. Users should log their vitamin D supplementation consistently and share this information with their healthcare provider at prenatal visits.
- Track vitamin D levels at each trimester through lab work ordered by your healthcare provider. Record the date and result of each vitamin D test in the app. Monitor for any signs of preterm labor and report them immediately to your doctor. Keep a running log of supplementation compliance and any side effects. Share this data with your healthcare team to help identify whether vitamin D status correlates with your individual pregnancy outcomes.
This article summarizes research findings and is not medical advice. Vitamin D status during pregnancy should be managed under the guidance of your healthcare provider. The findings from this single, small study should not be used to make changes to your vitamin D supplementation or prenatal care without consulting your doctor. Preterm birth has multiple causes, and vitamin D is only one potential factor. If you are pregnant or planning pregnancy, discuss appropriate vitamin D screening and supplementation with your healthcare team based on your individual risk factors and medical history. If you experience signs of preterm labor such as vaginal bleeding, fluid leakage, or regular contractions before 37 weeks, seek immediate medical attention.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.